RJA
SWAV

Raymond James & Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Raymond James & Associates’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,485
Closed -$4.39M – 4116
2024
Q1 		$4.39M Buy
13,485
+6,450
+92% +$1.58M ﹤0.01% 1683
2023
Q4 		$1.34M Sell
7,035
-1,809
-20% -$342K ﹤0.01% 2348
2023
Q3 		$1.76M Sell
8,844
-24,668
-74% -$5.83M ﹤0.01% 2094
2023
Q2 		$9.56M Buy
33,512
+28,603
+583% +$7.94M 0.01% 1072
2023
Q1 		$1.06M Sell
4,909
-6,340
-56% -$1.24M ﹤0.01% 2420
2022
Q4 		$2.31M Sell
11,249
-4,188
-27% -$1.06M ﹤0.01% 1902
2022
Q3 		$4.29M Buy
15,437
+8,806
+133% +$2.24M ﹤0.01% 1468
2022
Q2 		$1.27M Buy
6,631
+1,987
+43% +$351K ﹤0.01% 2296
2022
Q1 		$963K Buy
4,644
+81
+2% +$13.4K ﹤0.01% 2623
2021
Q4 		$814K Sell
4,563
-4,741
-51% -$935K ﹤0.01% 2762
2021
Q3 		$1.92M Sell
9,304
-1,697
-15% -$333K ﹤0.01% 2139
2021
Q2 		$2.09M Buy
11,001
+7,480
+212% +$1.22M ﹤0.01% 2061
2021
Q1 		$459K Buy
3,521
+1,568
+80% +$188K ﹤0.01% 3080
2020
Q4 		$203K Buy
+1,953
New +$169K ﹤0.01% 3395
2019
Q3 		– Sell
-14,835
Closed -$847K – 3738
2019
Q2 		$847K Buy
+14,835
New +$720K ﹤0.01% 2319

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Raymond James & Associates's SWAV Position: Q2 2024 in Review

Raymond James & Associates sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 13,485 shares — an estimated $4.39M sold.

Raymond James & Associates first reported a position in SWAV in Q2 2019 and held it in 15 quarters. The position peaked at $9.56M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Raymond James & Associates reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 13,485 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $4.39M.
  • Raymond James & Associates first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 15 quarters.
  • Raymond James & Associates's Shockwave Medical, Inc. Common Stock position peaked at $9.56M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.